Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2005
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267125 High drug load tablet
12/01/2005US20050267088 Compositions for treating hyperemia
12/01/2005US20050267084 Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate
12/01/2005US20050267082 Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate
12/01/2005US20050267069 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
12/01/2005US20050267067 Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267052 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
12/01/2005US20050267042 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
12/01/2005US20050267033 Multi-dose erythropoietin formulations
12/01/2005US20050266460 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
12/01/2005US20050266099 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
12/01/2005US20050266093 Nanogene therapy for cell proliferation disorders
12/01/2005US20050266092 Loaded microspheres
12/01/2005US20050266091 Method and apparatus for preparing microparticles using in-line solvent extraction
12/01/2005US20050266090 Nanoparticular targeting and therapy
12/01/2005US20050266089 Contact lens and eye drop rewetter compositions and methods
12/01/2005US20050266088 Formulation for fast dissolution of lipophilic compounds
12/01/2005US20050266087 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
12/01/2005US20050266086 Intrauterine applications of materials formed in situ
12/01/2005US20050266085 Gelled emulsion and microemulsion formulations for dermal drug delivery
12/01/2005US20050266084 Modified release dosage forms
12/01/2005US20050266083 Vehicles for delivery of biologically active substances
12/01/2005US20050266082 Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
12/01/2005US20050266081 Antimicrobial silver hydrogels
12/01/2005US20050266080 Coated tablet formulation and method
12/01/2005US20050266079 Process for making aqueous coated beadlets
12/01/2005US20050266078 Compressed tablets comprising microcapsules with modified release
12/01/2005US20050266077 Resorbable matrices with coatings for delivery of bioactive compounds
12/01/2005US20050266076 Resorbable delivery systems for the treatment of cancer
12/01/2005US20050266075 Omeprazole dosage form
12/01/2005US20050266074 Ingestible device platform for the colon
12/01/2005US20050266073 Fast disintegrating granules containing bromhexin/bromhexinhydrochloride, process for their preparation, and their use in veterinary medicine
12/01/2005US20050266072 Pharmaceutical compositions
12/01/2005US20050266071 Acid labile proton pump inhibitor microencapsulated with material that enhances shelf-life of pharmaceutical formulation, and antacid, wherein initial serum concentration of proton pump inhibitor is greater than 0.1 mu g/ml at any time within 30 minutes after administration of pharmaceutical; shelf life
12/01/2005US20050266070 Administering composition comprising hydrocodone covalently bound to a peptide; decreasing the bioavailability by intravenous or intranasal administration
12/01/2005US20050266069 Stable probiotic microsphere compositions and their methods of preparation
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050266067 Nanocell drug delivery system
12/01/2005US20050266066 Phospholipid membrane preparation
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
12/01/2005US20050266064 Cosmetic compositions and methods
12/01/2005US20050266063 Adhesive patch
12/01/2005US20050266062 Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one
12/01/2005US20050266061 Transdermal delivery of cannabinoids
12/01/2005US20050266060 Transdermal delivery system for treatment of cognitive disorders
12/01/2005US20050266059 Heel moisturizing patch
12/01/2005US20050266058 Topical preparations containing ambroxol
12/01/2005US20050266056 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer
12/01/2005US20050266054 Process of manufacturing antiseptic and scented clothe with cooling effect
12/01/2005US20050266046 Novel IGF-1 composition and its use
12/01/2005US20050266042 Methods and apparatus for treatment of aneurysmal tissue
12/01/2005US20050266035 Skin protectant spray compositions
12/01/2005US20050266033 Generation of therapeutic microfoam
12/01/2005US20050266031 Pharmaceutical suspension composition
12/01/2005US20050266024 Adjuvant
12/01/2005US20050266021 Powder compositions
12/01/2005US20050265991 For controlled release of compounds through the use of a chemically sensitive cantilever
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005US20050265964 Stabilizing agent such as polyhydric alcohol or salt, a buffer , a sugar and polymeric compound for minimizing degradation of multifunctional glycoprotein (leukaemia inhibitory factor), additive to maintain acidic ph and isotonicity, and carriers
12/01/2005US20050265963 Immunodynamic complexes and methods for using and preparing such complexes
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005US20050265955 Sustained release preparations
12/01/2005US20050265947 Method for thickening hair and hair thickener
12/01/2005US20050265945 Method for thickening hair and hair thickener
12/01/2005US20050265929 Composition packaged in an aerosol device, comprising at least one anionic fixing polymer, at least one silicone oxyalkylenated in the alpha and omega positions of the silicone chain, and at least one propellant
12/01/2005US20050265928 Pulmonary malarial vaccine
12/01/2005US20050265927 Intranasal delivery of nucleic acid molecules
12/01/2005US20050265926 Methods and reagents for improving localization of treatment and visualization ligands to sites in a mammal
12/01/2005US20050265925 Conjugates containing a lipid or a hydrophilic polymer, linked to a ligand derived from an amine- or hydroxyl-containing compound, such as a drug or protein, are stable under conditions of storage, and are cleavable under mild thiolytic conditions to regenerate the ligand
12/01/2005US20050262765 Floral packaging material having great masters prints thereon
12/01/2005DE10342095B4 Verwendung einer Applikationsanordnung für auf die Haut aufzutragende, tinkturartige Heilmittel Using a delivery arrangement for be applied to the skin, tinkturartige remedies
12/01/2005DE102004024199A1 Kosmetische oder dermatologische getränkte Tücher Cosmetic or dermatological impregnated wipes
12/01/2005CA2838526A1 Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer
12/01/2005CA2567532A1 Methods for making injectable polymer hydrogels
12/01/2005CA2567348A1 Encapsulated transfer factor compositions and methods of use
12/01/2005CA2567333A1 Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them
12/01/2005CA2567329A1 Rapid setting calcium phosphate cements
12/01/2005CA2567297A1 Tissue sealant
12/01/2005CA2566174A1 Treatment of lung diseases and pre-lung disease conditions
12/01/2005CA2566079A1 Nucleic acid microspheres, production and delivery thereof
12/01/2005CA2566075A1 Microspheres comprising protein and showing injectability at high concentrations of said agent
12/01/2005CA2566032A1 Apparatus and method for transdermal delivery of parathyroid hormone agents
12/01/2005CA2565747A1 Medicinal aerosol formulation products with improved chemical stability
12/01/2005CA2565253A1 Dosage form for delivery of multiple drug forms
12/01/2005CA2565029A1 Immediate release pharmaceutical tablets with height greater than width
12/01/2005CA2565019A1 1,4 o-linked saccharose derivatives for stabilizing antibodies or antibody derivatives
12/01/2005CA2564962A1 Pharmaceutical tablets comprising two or more unitary segments
12/01/2005CA2564961A1 Pharmaceutical tablets having a relatively inactive segment
12/01/2005CA2564960A1 Pharmaceutical tablets having a separation mark positioned on the side of said tablets
12/01/2005CA2564332A1 Powders containing novel oligosaccharide mixtures and methods for producing the same
12/01/2005CA2564324A1 Spray-dried powders containing at least one 1,4 o-linked saccharose derivative and methods for producing the same
12/01/2005CA2562990A1 Mucinous glycoprotein (muc-1) vaccine
12/01/2005CA2562044A1 Methods and systems for providing an interface between an ambulatory medical device and a display device
12/01/2005CA2508585A1 Transdermal delivery system for treatment of cognitive disorders
12/01/2005CA2469427A1 Dry mixed dosage form containing benzimidazole derivatives
11/2005
11/30/2005EP1600906A1 Communication unit for a person's skin
1 ... 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 ... 2991